LĀ 02.18. Tabakas produktu veidi, to ietekme uz veselību un izaicinājumi, ar ko mums būs jāsaskaras nākotnē. Māris Bukovskis, Dr.med.
LATVIJAS ĀRSTS, 2018. gada februāris
Tabakas produktu veidi, to ietekme uz veselību un izaicinājumi, ar ko mums būs jāsaskaras nākotnē
Māris Bukovskis, Dr.med.
1. Fidler J, West R. Self-perceived smoking motives and their correlates in a general population sample. Nicotine & Tobacco Research 2009; 11: 1182–1188.
2. Royal College of Physicians, 2016. Nicotine without smoke: tobacco harm reduction. Royal College of Physicians, London.
3. US Department of Health and Human Services, 2010. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Surg. General 351e434.
4. Gowing, L. R., Ali, R. L., Allsop, S., Marsden, J., Turf, E. E., West, R., & Witton, J. (2015). Global statistics on addictive behaviours: 2014 status report. Addiction, 110, 904–919.
5. World Health Organization. WHO report on the global tobacco epidemic. Geneva, Switzerland: WHO Press; 2013.
6. World Health Organization. Monitoring Tobacco Use and Prevention Policies; World Health Organization: Geneva, Switzerland, 2017.
7. Hatsukami, D.K.; Stead, L.F.; Gupta, P.C. Tobacco addiction. Lancet 2008, 371, 2027-2038.
8. Davis, R.M.; Wakefield, M.; Amos, A.; Gupta, P.C. The hitchhiker‘s guide to tobacco control: A global assessment of harms, remedies, and controversies. Annu. Rev. Public Health 2007, 28, 171-194.
9. Jamal, A.; King, B.A.; Neff, L.J.; Whitmill, J.; Babb, S.D.; Graffunder, C.M. Current cigarette smoking among adults—United States, 2005–2015. Morb. Mortal. Wkly. Rep. 2016, 65, 1205–1211.
10. Vink, J. M., Willemsen, G., & Boomsma, D. I. (2005). Heritability of smoking initiation and nicotine dependence. Behavior Genetics, 35, 397–406.
11. Lauria L, Lamberti A, Grandolfo M. Smoking behaviour before, during, and after pregnancy: the effect of breastfeeding. Sci World J. 2012; doi:10.1100/2012/154910.
12. EURO-PERISTAT. European Perinatal Health Report by the EURO-PERISTAT project in collaboration with SCPE, EUROCAT & EURONEOSTAT, 2008. http://www.europeristat.com. Accessed 24 Mar 2015.
13. Borgerding, M.; Klus, H. Analysis of complex mixtures—cigarette smoke. Exp. Toxicol. Pathol. 2005, 57, 43-73.
14. Rodgman, A., Perfetti, T.A., 2013. The Chemical Components of Tobacco and Tobacco Smoke, second ed. CRC Press, Boca Raton.
15. Thielen, A.; Klus, H.; Muller, L. Tobacco smoke: unraveling a controversial subject. Exp. Toxicol. Pathol. 2008, 60, 141-156.
16. Fowles, J.; Dybing, E. Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob. Control 2003, 12, 424-430.
17. Ezzati, M.; Lopez, A.D. Estimates of global mortality attributable to smoking in 2000. Lancet 2003, 362, 847-852.
18. Hoffmann, D.; Hoffmann, I. The changing cigarette, 1950–1995. J. Toxicol. Environ. Health 1997, 50, 307-364.
19. Hoffmann, D.; Hoffmann, I.; El Bayoumy, K. The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder. Chem. Res. Tox. 2001, 14, 767-790.
20. Talhout R, Schulz T, Florek E, van Benthem J, Wester P, Opperhuizen A. Hazardous compounds in tobacco smoke. Int J Environ Res Public Health. 2011 Feb;8(2):613-28. doi: 10.3390/ijerph8020613. Epub 2011 Feb 23.
21. International Organisation for Standardization, 2013. ISO 10315:2013, Cigarettes e Determination of Nicotine in Smoke Condensates e Gas-chromatographic Method. http://www.iso.org/iso/home/store/catalogue_tc/catalogue_detail. htm?csnumber¼56744.
22. World Health Organisation, 2008. The Scientific Basis of Tobacco Product Regulation. Report of aWHO Study Group (TobReg). WHO Technical Report Series 945, Geneva. http://www.who.int/tobacco/global_interaction/tobreg/publications/ tsr_951/en/.
23. U.S. Food and Drug Administration, 2012. Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke; Established List. Federal Register Food and Drug Administration, 77, 20034. http://www.fda. gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM297981.pdf.
24. Health Canada, 2000. Health Canada – Tobacco Products Information Regulations SOR/2000-273, Schedule 2. http://laws-lois.justice. gc.ca/PDF/SOR-2000-273.pdf.
25. U.S. Food and Drug Administration, 2016. Harmful and Potentially Harmful Constituents” in Tobacco Products as Used in Section 904(e) of the Federal Food, Drug, and Cosmetic Act (Revised)*. http://www.fda. gov/downloads/TobaccoProducts/Labeling/RulesRegulationsGuidance/UCM241352.pdf.
26. Stohs, S.J.; Bagchi, D.; Bagchi, M. Toxicity of trace elements in tobacco smoke. Inhal. Toxicol. 1997, 9, 867-890.
27. Talhout, R.; Opperhuizen, A.; van Amsterdam, J.G. Sugars as tobacco ingredient: Effects on mainstream smoke composition. Food Chem. Toxicol. 2006, 44, 1789-1798.
28. Nicotine|C10H14N2—PubChem. Available online: https://pubchem.ncbi.nlm.nih. gov/compound/ 89594#
29. Doering, P.L.; Li, R.M. Substance-related disorders II: Alcohol, nicotine, and caffeine. In Pharmacotherapy: A Pathophysiologic Approach, 9th ed.; DiPiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M., Eds.; The McGraw-Hill Companies: New York, NY, USA, 2014.
30. Soghoian, S. Nicotine. In Goldfrank’s Toxicologic Emergencies, 10th ed.; Hoffman, R.S., Howland, M.A., Lewin, N.A., Nelson, L.S., Goldfrank, L.R., Eds.; McGraw-Hill Education: New York, NY, USA, 2015.
31. O’Brien, C.P. Drug addiction. In Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 12th ed.; Brunton, L.L., Chabner, B.A., Knollmann, B.C., Eds.; McGraw-Hill Education: New York, NY, USA, 2011.
23. Nicotine 2D Structure. Available online: https://pubchem.ncbi.nlm.nih. gov/image/ imagefly.cgi?cid=89594&width=500& height=500
32. Benowitz, N. L. (1997). The role of nicotine in smoking-related cardiovascular disease. Preventive Medicine, 26, 412–417.
33. Benowitz, N. L. (1998). Nicotine safety and toxicity. Oxford: Oxford University Press.
34. Lisboa PC, de Oliveira E, de Moura EG. Obesity and endocrine dysfunction programmed by maternal smoking in pregnancy and lactation. Front Physiol. 2012;3:437.
35. Royal College of Physicians, 2007. Harm Reduction in Nicotine Addiction_helping People Who Can’t Quit. A Report by the Tobacco Advisory Group of the Royal College of Physicians. London.
36. Benowitz, N.L.; Hukkanen, J.; Jacob, P. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb. Exp. Pharmacol. 2009, 192, 29–60.
37. Proctor RN. Golden holocaust: origins of the cigarette catastrophe and the case for abolition. Berkeley, CA: University of California Press; 2011.
38. Brandt A. The cigarette century: the rise, fall, and deadly persistence of the product that defined America. New York: Basic Books; 2007.
39. Hu, S.S.; Neff, L.; Agaku, I.T.; Cox, S.; Day, H.R.; Holder-Hayes, E.; King, B.A. Tobacco product use among adults—United States, 2013–2014. Morb. Mortal. Wkly. Rep. 2016, 65, 685–691.
40. Cullen J, Mowery P, Delnevo C, Allen JA, Sokol N, Byron MJ, et al. Seven-year patterns in US cigar use epidemiology among young adults aged 18–25 years: a focus on race/ethnicity and brand. Am J Public Health. 2011;101:1955–62.
41. Baker, R.R., 1975. Temperature variation within a cigarette combustion coal during the smoking cycle. High. Temp. Sci. 7, 236e247.
42. Torikaiu, K., Uwano, Y., Nakamori, T., Tarora, W., Takahashi, H., 2005. Study on tobacco components involved in the pyrolytic generation of selected smoke constituents. Food Chem. Toxicol. 43, 559e568. http://www.sciencedirect.com/ science/article/pii/S0278691505000104.
43. Piade, J.J., Wajrock, S., Jaccard, G., Janeke, G., 2013. Formation of mainstream cigarette smoke constituents prioritized by the World Health Organization e yield patterns observed in market surveys, clustering and inverse correlations. Food Chem. Toxicol. 55, 329e347. ttp://www.sciencedirect.com/science/article/pii/S0278691513000549.
44. Bing RJ, Davies DF, Dyer RE, Lilienfeld AM, Nelson N, Shimkin MB, Spain DM, Strong FM. Report of study group on smoking and health. San Francisco, CA: Legacy Tobacco Documents Library, UCSF; March 6, 1957. [cited 2002 Feb 1]. Available from: http://legacy.library.ucsf.edu/tid/bdl68e00.
45. Burney LE. Excessive cigarette smoking. Public Health Reports, July 12, 1957, Pg 786. San Francisco CA: Legacy Tobacco documents Library, UCSF. [cited 2011 Apr 28]. Available from: http://legacy. Library.ucsf.edu/tid/ofv08h00.
47. Jha, P., & Peto, R. (2014). Global effects of smoking, of quitting, and of taxing tobacco. New England Journal of Medicine, 370, 60–68.
48. U.S. Department of Health and Human Services. The Health Consequences of Smoking – 50 Years of Progress: A Report of the Surgeon General; Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA, USA, 2014; pp. 1–36
49. Global Initiative for Chronic Obsructive Lung Disease (GOLD) 2017. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. Global Initiative for Chronic Obsructive Lung Disease. 2017. Available online: http://goldcopd.org/gold-2017-global-strategy-diagnosismanagement-prevention-copd/ (accessed on 10 January 2017).
50. United States Department of Health and Human Services. How Tobacco Smoke Causes Disease: A Report of the Surgeon General; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA, USA, 2010.
51. Benowitz, N.L.; Brunetta, P.G. Smoking Hazards and Cessation, 5th ed.; Elsevier Inc.: Amsterdam, The Netherlands, 2010.
52. Ko TJ, Tsai LY, Chu LC, Yeh SJ, Leung C, Chen CY, et al. Parental smoking during pregnancy and its association with low birth weight, small for gestational age, and preterm birth offspring: a birth cohort study. Pediatr Neonatol. 2014;55:20–7.
53. Blatt K, Moore E, Chen A, Van Hook J, DeFranco E. Association of reported trimester-specific smoking cessation with fetal growth restriction. Obstet Gynecol. 2015;125:1452–9.
54. Harrod CS, Reynolds RM, Chasan-Taber L, Fingerlin TE, Glueck DH, Brinton JT, Dabelea D. Quantity and timing of maternal prenatal smoking on neonatal body composition: the healthy start study. J Pediatr. 2014;165:707–12.
55. Machado J de B, Filho Plķnio VM, Petersen GO, Chatkin JM. Quantitative effects of tobacco smoking exposure on the maternalfetal circulation. BMC Pregnancy Childbirth. 2011;11:24–9. doi:10.1186/1471-2393-11-24
56. Ekblad M, Korkeila J, Lehtonen L. Smoking during pregnancy affects foetal brain development. Acta Paediatr. 2015;104:12–8.
57. Ino T. Maternal smoking during pregnancy and offspring obesity: metaanalysis. Pediatr Int. 2010;52:94–9.
58. Oken E, Levitan EB, Gillman MW. Maternal smoking during pregnancy and child overweight: systematic review and meta analysis. Int J Obes. 2008;32:201–10.
59. Al Mamun A, Lawlor DA, Alati R, O’Callaghan MJ, Williams GM, Najman JM. Does maternal smoking during pregnancy have a direct effect on future offspring obesity? Evidence from a prospective birth cohort study. Am J Epidemiol. 2006;164:317–25.
60. Koshy G, Delpisheh A, Brabin BJ. Dose response association of pregnancy cigarette smoke exposure, childhood stature, overweight and obesity. Eur J Public Health. 2011;21:286–91.
61. Leary SD, Smith GD, Rogers IS, Reilly JJ, Wells JC, Ness AR. Smoking during pregnancy and offspring fat and lean mass in childhood. Obesity. 2006;14:2284–93.
62. Oken E, Huh SY, Taveras EM, Rich-Edwards JW, Gillman MW. Associations of maternal prenatal smoking with child adiposity and blood pressure. Obes Res. 2005;13:2021–8.
63. Brion MJ, Leary SD, Lawlor DA, Smith GD, Ness AR. Modifiable maternal exposures and offspring blood pressure: a review of epidemiological studies of maternal age, diet, and smoking. Pediatr Res. 2008;63:593–8.
64. Cheraghi M, Salvi S. Environmental tobacco smoke (ETS) and respiratory health in children. Eur J Pediatr. 2009;168:897–905.
65. Doherty SP, Grabowski J, Hoffman C, Ng SP, Zelikoff JT. Early life insult from cigarette smoke may be predictive of chronic diseases later in life. Biomarkers. 2009;14:97–101.
66. Maritz GS, Harding R. Life-long programming implications of exposure to tobacco smoking and nicotine before and soon after birth: evidence for altered lung development. Int J Environ Res Public Health. 2011;8:875–98.
67. Banderali G, Martelli A, Landi M, et al. Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review. J Transl Med. 2015 Oct 15;13:327. doi: 10.1186/s12967-015-0690-y.
68. Cummings KM. A promise is a promise. Tob Control 2003;12:117–8.
69. Leonardi-Bee J, Smyth A, Britton J, Coleman T. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008;93:F351–61.
70. Centers for Disease Control and Prevention (CDC); Consumption of cigarettes and combustible tobacco–United States, 2000–2011. MMWR Morb Mortal Wkly Rep 2012, 61:565–569.
71. Hoffmann D, Hoffmann I. Chemistry and Toxicology. National Cancer Institute, Smoking and Tobacco Control, Monograph 9: Cigars Health Effects and Trends 1998,55-104 http://cancercontrol.cancer. gov/brp/tcrb/monographs/ .
72. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans; Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004, 83:1–1438.
73. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer. 2004;45 Suppl 2:S3–9.
74. Wyss A, Hashibe M, Chuang SC, Lee YCA, Zhang ZF, Yu GP, et al. Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the international head and neck cancer epidemiology consortium 1122. Am J Epidemiol. 2013;178:679–90.
75. Nonnemaker J, Rostron B, Hall P, MacMonegle A, Apelberg B. Mortality and economic costs from regular cigar use in the United States, 2010. Am J Public Health. 2014 Sep;104(9): e86-91.
76. Chang CM, Corey CG, Rostron BL, Apelberg BJ. Systematic review of cigar smoking and all cause and smoking related mortality. BMC Public Health. 2015 Apr 24;15:390.
77. McDonald LJ, Bhatia RS, Hollett PD. Deposition of cigar smoke particles in the lung: evaluation with ventilation scan using (99 m) Tc-labeled sulfur colloid particles. J Nucl Med. 2002;43:1591–5.
78. Ray C. The hookah – the Indian waterpipe. Curr Sci. 2009;96(10): 1319–1323.
79. Akl E, Jawad M, Lam W, Co C, Obeid R, Irani J. Motives, beliefs and attitudes towards waterpipe tobacco smoking: a systematic review. Harm Redut J. 2013;10:12.
80. Cavazos-Regq PA, Krauss MJ, Kim Y, Emery SL. Risk factors associated with hookah use. Nicotine Tob Res. Epub 2015 Feb 2.
81. Maziak W, Ward KD, Eissenberg T. Interventions for waterpipe smoking cessation. Cochrane Database Syst Rev. 2007;4:CD005549.
82. Barnett TE, Forrest JR, Porter L, Curbow BA. A multiyear assessment of hookah use prevalence among Florida high school students. Nicotine Tob Res. 2014;16(3):373–377.
83. Safizadeh H, Moradi M, Rad MR, Nakhaee N. Bacterial contamina¬tion of different components of the waterpipe. Int J Tuberc Lung Dis. 2014;18:988–991.
84. Shubert J, Hahn J, Dettbarn G, Seidel A, Luch A, Schulz TG. Mainstream smoke of the waterpipe: does this environmental matrix reveal as significant source of toxic compounds? Toxicol Lett. 2011;205(3): 279–284.
85. La Fauci G, Weiser G, Steiner IP, Savit I. Carbon monoxide poisoning in narghile (water pipe) tobacco smokers. CJEM. 2012;14(1):57–59.
86. Jabbour S, El-Roueiheb Z, Sibai A. Nargileh (water-pipe) smoking and incident coronary heart disease: a case-control study. Ann Epidemiol. 2001;8:570.
87. Kiter G, Ucan ES, Ceylan E, Kilinc O. Water-pipe smoking and pul¬monary functions. Respir Med. 2000;94(9):891–894.
88. Villanti A, Cobb C, Cohn A, Williams V, Rath J. Correlates of hookah use and predictors of hookah trial in US young adults. Am J Prev Med. 2015;48(6):742–746.
89. Jamil HE, Elsouhaq D, Hiller S, Arnetz JE, Arnetz BB. Sociodemographic risk indicators of hookah smoking among white Americans: a pilot study. Nicotine Tob Res. 2010;12(5):525–529.
90. World Health Organization. Waterpipe Tobacco Smoking: Health Effects, Research Needs and Recommended Actions by Regulators. Tob Reg. 2005:1–11. Available from: http://www.who.int/tobacco/global_interaction/tobreg/waterpipe/en/. Accessed June 6, 2015.
91. D’Ruiz, C.D.; Graff, D.W.; Yan, X.S. Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes. BMC Public Health 2015, 15, 991.
92. Laugesen M. Ruyan e-cigarette bench-top tests Poster. Soc Res Nicotine Tob 2009. http://www.healthnz.co.nz/DublinEcigBenchtopHandout (accessed 16 Nov 2012).
93. Cahn Z, Seigel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward of a repeat of past mistakes? J Public Health Policy 2011;32:16–31.
94. Pellegrino RM, Tinghino B, Mangiaracina G, et al. Electronic cigarettes: an evaluation of exposure to chemicals and fine particulate matter (PM). Ann Ig 2012;24:279–88.
95. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 2014;23:133–9.
96. Polosa R, Morjaria JB, Caponnetto P, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med Published Online First: 20 Jul 2013. doi:10.1007/s11739-013-0977-z
97. Vardavas CI, Anagnostopoulos N, Kougias M, et al. Short-term pulmonary effects of using an electronic cigarette. Chest 2012;141:1400–6.
98. Vansickel AR, Cobb CO, Weaver MF. A clinical laboratory model for evaluating the acute effects of electronic cigarettes: nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev 2010;19:1945–53.
99. Flouris AD, Poulianiti KP, Chorti MS, et al. Acute effects of electronic and tobacco cigarette smoking on complete blood count. Food Chem Toxicol 2012;50:3600–3.
100. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 2013;25:91–101.
101. Farsalinos K, Tsiapras D, Kyrzopoulos S, et al. Acute effects of using an electronic nicotine-delivery device (e-cigarette) on myocardial function: comparison with the effects of regular cigarettes. Eur Heart J 2012;33(Supp 1):203.
102. Tzatzarakis MN, Tsitoglou KI, Chorti MS, et al. Acute and short term impact of active and passive tobacco and electronic cigarette smoking on inflammatory markers. Toxicol Lett 2013;221S:S86.
103. Cheah NP, Chong NW, Tan J, et al. Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective. Tob Control 2014;23:119–25.
104. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users (Embase)[Article in Press]. Berlin, Heidelberg: Springer-Verlag, 2013:1–7.
105. Trtchounian A, Williams M, Talbot P. Conventional and electronic cigarettes (e-cigarettes) have different smoking characteristics. Nicotine Tob Res 2010;12:905–12.
106. Schripp T, Markewitz D, Uhde E, et al. Does e-cigarette consumption cause passive vaping? Indoor Air 2013;23:25–31.
107. Ordonez J, Forrester MB, Kleinschmidt K. Electronic cigarette exposures reported to poison centers. Clin Toxicology 2013;51:685.
108. U.S. Department of Health and Human Services. E-Cigarette Use among Youth and Young Adults: A Report of the Surgeon General; Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA, USA, 2016.
109. Centers for Disease Control and Prevention Office of Smoking and Health. E-Cigarette Information; U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA,USA, 2015.
110. Protano, C.; Di Milia, L.M.; Orsi, G.B.; Vitali, M. Electronic cigarette: A threat or an opportunity for public health? State of the art and future perspectives. Clin. Ter. 2015, 166, 32–37.
111. ENVIRON International Corporation. Equipment-based guidelines for the use of theatrical smoke and haze. Report prepared for Equity-League Pension and Health Trust Funds, 2001. http://www.actorsequity.org/docs/safesan/equipment-based.pdf (accessed July 2013).
112. Raymond GE. Recommended exposure guidelines for glycol fogging agents. Report prepared for Entertainment Services and Technology Association, 1997. http://www. lemaitreltd.com/pdf/Cohen%20Report.pdf (accessed July 2013).
113. Thornton S, Oller L, Sawyer T. Fatal intravenous injection of electronic “eLiquid” solution. Annual Meeting of North American Congress of Clinical Toxicology. Clin Toxicology 2013;51:238.
114. Valento M. Nicotine poisoning following ingestion of e-Liquid. Annual Meeting of North American Congress of Clinical Toxicology. Clin Toxicology 2013;51:239.
115. Christensen LB, Van’t Veen T, Bang J. Three cases of attempted suicide by ingestion of nicotine liquid used in e-cigarettes. Clin Toxicology 2013;51:290.
116. Benowitz NL, Goniewicz ML. The Regulatory Challenge of Electronic Cigarettes. JAMA 2013;310:685–6.
117. Sleiman, M., Logue, J.M., Montesinos, V.N., Russell, M.L., Litter, M.I., Gundel, L.A., Destaillats, H., 2016. Emissions from electronic cigarettes: key parameters affecting the release of harmful chemicals. Environ. Sci. Technol. 50, 9644e9651. http://dx.doi.org/10.1021/acs.est.6b01741.
118. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health 2010;10:231–7.
119. Siegel MB, Tanwar KL, Wood KS. Electronic cigarettes as a smoking-cessation tool. Am J Prev Med 2011;40:472–5.
120. Popova L, Ling PM. Alternative tobacco product use and smoking cessation: a national study. Am J Public Health 2013;103:923–30.
121. Bullen C, McRobbie H, Thornley S, et al. Effect of an electronic nicotine delivery device on desire to smoke and withdrawal, user preferences and nicotine delivery: randomized cross-over trial. Tob Control 2010;19:98–103.
122. Polosa R, Caponnetto P, Morjaria JB, et al. Effect of an electronic nicotine delivery device on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011;11:786–98.
123. Caponnetto P, Campagna D, Cibella F, et al. Efficiency and safety of an electronic cigarette (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS ONE 2013;8:e66317. http://www.plosone.org.
124. Caponnetto P, Auditore R, Russo C, et al. Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a 12-month prospective pilot study. Int J Environ Res Public Health 2013;10:446–61.
125. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomized controlled trial. Lancet 2013;382:1629–37.
126. Farsalinos KE, Romagna G, Tsiapras D, et al. Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse 2013;3:139–46.
127. Callahan-Lyon, P. Electronic cigarettes: Human health effects. Tob. Control 2014.
128. Rahman, M.A.; Hann, N.;Wilson, A.;Worrall-Carter, L. Electronic cigarettes: Patterns of use, health effects, use in smoking cessation and regulatory issues. Tob. Induc. Dis. 2014, 12, 21.
129. International Agency for Research on Cancer: Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. Volume 89. Lyon, France: IARC; 2007. (Accessed Oct 2010). [IARC Monographs on the evaluation of carcinogenic risks to humans.] http://monographs.iarc.fr/ENG/Monographs/vol89/mono89.pdf.
130. Weitkunat R, Sanders E, Lee PN: Meta-analysis of the relation between European and American smokeless tobacco and oral cancer. BMC Public Health 2007, 7:334.
131. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR): Health Effects of Smokeless Tobacco Products. Brussels: European Commission, Health & Consumer Protection Directorate-General; 2008. (Accessed Oct 2010). http://ec.europa.eu/health/ph_risk/committees/04_ scenihr/docs/scenihr_o_013.pdf.
132. Brunnemann KD, Hoffman D: Chapter 3. Carcinogenesis. Chemical composition of smokeless tobacco products. In Smokeless Tobacco or Health. An international perspective. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1992:96–108. [Smoking and tobacco control. Monograph No. 2.] NIH. Publication No. 92-3461.
133. Brunnemann KD, Qi J, Hoffman D: Aging of Oral Moist Snuff and the Yields of Tobacco-Specific N-Nitrosamines (TSNA), Progress Report. American Health Foundation; 2001.
134. Holm H, Jarvis MJ, Russell MAH, Feyerabend C: Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl) 1992, 108:507–511.
136. Sponsiello-Wang Z, Weitkunat R, Lee PN: Systematic review of the relation between smokeless tobacco and cancer of the pancreas in Europe and North America. BMC Cancer 2008, 8:356.
137. Luo J, Ye W, Zendehdel K, Adami J, Adami H-O, Boffetta P, Nyrén O: Oral use of Swedish moist snuff (snus) and risk of cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007, 369:2015–2020.
138. Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, Fontham ET, Bamlet WR, Holly EA, Lucenteforte E, Hassan M, Yu H, Kurtz RC, Cotterchio M, Su J, Maisonneuve P, Duell EJ, Bosetti C, Boffetta P: Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the international pancreatic cancer case-control consortium (PanC4). Ann Oncol 2011, 22:1420–1426.
139. Boffetta P, Aagnes B, Weiderpass E, Andersen A: Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 2005, 114:992–995.
140. Lee PN: Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 2011, 59:197–214.
141. Roosaar A, Johansson ALV, Sandborgh-Englund G, Nyrén O, Axéll T: A longterm follow-up study on the natural course of snus-induced lesions among Swedish snus users. Int J Cancer 2006, 119:392–397.
142. Hansson J, Galanti MR, Hergens M-P, Fredlund P, Ahlbom A, Alfredsson L, Bellocco R, Eriksson M, Hallqvist J, Hedblad B, Jansson J-H, Nilsson P, Pedersen N, Lagerros YT, Östergren P-O, Magnusson C: Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol 2012, 27:771–779.
143. Hugoson A, Rolandsson M: Periodontal disease in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983-2003). J Clin Periodontol 2011, 38:809–816.
144. Hugoson A, Hellqvist L, Rolandsson M, Birkhed D: Dental caries in relation to smoking and the use of Swedish snus: epidemiological studies covering 20 years (1983-2003). Acta Odontol Scand 2012, 70:289–296.
145. Bergström J, Keilani H, Lundholm C, Rådestad U: Smokeless tobacco (snuff) use and periodontal bone loss. J Clin Periodontol 2006, 33:549–554.
146. Rolandsson M, Hellqvist L, Lindqvist L, Hugoson A: Effects of snuff on the oral health status of adolescent males: a comparative study. Oral Health Prev Dent 2005, 3:77–85.
147. T Lee PN. The effect on health of switching from cigarettes to snus – a review. Regul Toxicol Pharmacol. 2013 Jun;66(1):1-5. doi: 10.1016/j.yrtph.2013.02.010. Epub 2013 Feb 26.
148. Lund I, Lund, KE. How has the availability of snus influenced cigarette smoking in Norway? International Journal of Environmental Research and Public Health 2014; 11, 11705–11717.
149. Fischer R, Clair C, Studer J, Cornuz J, Gmel G. Prevalence and factors associated with use of smokeless tobacco in young Swiss men. Eur J Public Health. 2014 Jun;24(3):459-64
150. Sapundzhiev N, Werner JA. Nasal snuff: historical review and health related aspects. J Laryngol Otol. 2003 Sep;117(9):686-91
151. Hatsukami, D.K.; Joseph, A.M.; Lesage, M.; Jensen, J.; Murphy, S.E.; Pentel, P.R.; Kotlyar, M.; Borgida, E.; Le, C.; Hecht, S.S. Developing the science base for reducing tobacco harm. Nicotine Tob. Res. 2007, 9, S537-S553.
152. Family Smoking Prevention and Tobacco Control Act. Public Law No. 111e131 (June 22, 2009).
153. McNeil, A., 2012. Reducing Harm from Nicotine Use. Fifty Years since Smoking and Health. Progress, Lessons and Priorities for a Smoke-free UK. Royal College of Physcians, London.
154. Smith MR, Clark B, Lüdicke F, Schaller JP, Vanscheeuwijck P, Hoeng J, Peitsch MC. Evaluation of the Tobacco Heating System 2.2. Part 1: Description of the system and the scientific assessment program. Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S17-S26. doi: 10.1016/j.yrtph.2016.07.006. Epub 2016 Jul 19. Review.
155. Cozzani, V., Mc Grath, T., Smith, M., Schaller, J.-P., Zuber, G., 2016. Absence of combustion in an electrically heated tobacco system – an experimental investigation. In: 21st International Symposium on Analytical and Applied Pyrolysis. Nancy, France. 9th-12th of May 2016. https://www.pmiscience.com/library/ absence-combustion-electrically-heated-tobacco-system-experimentalinvestigation (Accessed 06.2016).
156. Schaller JP, Keller D, Poget L, Pratte P, Kaelin E, McHugh D, Cudazzo G, Smart D, Tricker AR, Gautier L, Yerly M, Reis Pires R, Le Bouhellec S, Ghosh D, Hofer I, Garcia E, Vanscheeuwijck P, Maeder S. Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosol. Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S27-S47. doi: 10.1016/j.yrtph.2016.10.001. Epub 2016 Oct 6.
157. Mitova MI, Campelos PB, Goujon-Ginglinger CG, Maeder S, Mottier N, Rouget EG, Tharin M, Tricker AR.Comparison of the impact of the Tobacco Heating System 2.2 and a cigarette on indoor air quality. Regul Toxicol Pharmacol. 2016 Oct;80:91-101. doi: 10.1016/j.yrtph.2016.06.005. Epub 2016 Jun 14.
158. Tricker, A.R., Schorp, M.K., Urban, H.G., Leyden, D., Hagerdorn, H.W., Engl, J., Urban, M., Riedel, K., Gilch, G., Janket, D., Scherer, G., 2009. Comparison of environmental tobacco smoke (ETS) concentrations generated by an electronically heated cigarette smoking system and a conventional cigarette. Inhal. Toxicol. 21, 62e77. http://dx.doi.org/10.1080/08958370802207334.
159. Wong ET, Kogel U, Veljkovic E, Martin F, et al. Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke. Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S59-S81. doi: 10.1016/j.yrtph.2016.10.015. Epub 2016 Oct 26.
160. National Center for Chronic Disease Prevention and Health Promotion (2014P). The health consequences of smoking-50 years of progress: A report of the surgeon general. Atlanta (GA): Centers for Disease Control and Prevention (US).
161. Johnston, L. D., Miech, R. A., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2014a). Use of alcohol, cigarettes, and number of illicit drugs declines among U.S. teens. Ann Arbor, MI: University of Michigan News Service.
162. Jarvis, M.J.; Boreham, R.; Primatesta, P.; Feyerabend, C.; Bryant, A. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: Evidence from a representative population survey. J. Natl. Cancer Inst. 2001, 93, 134-138.
163. Jarvis, M.J.; Boreham, R.; Primatesta, P.; Feyerabend, C.; Bryant, A. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: Evidence from a representative population survey. J. Natl. Cancer Inst. 2001, 93, 134-138.
164. Hammond, D.; Wiebel, F.; Kozlowski, L.T.; Borland, R.; Cummings, K.M.; O‘Connor, R.J.; McNeill, A.; Connolly, G.N.; Arnott, D.; Fong, G.T. Revising the machine smoking regime for cigarette emissions: Implications for tobacco control policy. Tob. Control 2007, 16, 8-14.
165. Cummings, K.M.; Hyland, A.; Bansal, M.A.; Giovino, G.A. What do Marlboro Lights smokers know about low-tar cigarettes? Nicotine Tob. Res. 2004, 6, S323-S332.
166. Dunlop, S.M.; Romer, D. Relation between newspaper coverage of ‘light‘ cigarette litigation and beliefs about ‘lights‘ among American adolescents and young adults: the impact on risk perceptions and quitting intentions. Tob. Control 2010, 19, 267-273.